Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigationa...
Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)
About this item
Full title
Author / Creator
For the members of the Canadian Immunization Monitoring Program, Active (IMPACT) , members of the Canadian Immunization Monitoring Program, Active (IMPACT) , Bettinger, Julie A , Scheifele, David W , Halperin, Scott A , Vaudry, Wendy , Findlow, Jamie , Borrow, Ray , Medini, Duccio and Tsang, Raymond
Publisher
Kidlington: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Highlights • Predicted strain coverage in Canada for a new MenB vaccine is 66% (46–78%). • The vaccine may provide coverage across a wide diversity of endemic strains. • Two antigens (fHbp and NHBA) contribute the most to vaccine coverage. • Over two-thirds of MenB cases are potentially preventable with this vaccine.
Alternative Titles
Full title
Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1516751981
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1516751981
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2013.03.063
